ANN ARBOR–Coretec Group Inc. (OTCQB: CRTG), developers of engineered silicon and 3D volumetric displays, has entered into an agreement with Richman Chemical Inc. (RCI) to supply The Coretec Group’s Cyclohexasilane (CHS) to North American customers.
Due to increasing supply chain difficulties and overseas shipping delays due to the COVID-19 pandemic, it was important that Coretec Group work with a United States-based company to supply North American partners with CHS. On Nov. 15, The Coretec Group signed a supply agreement with Richman Chemical for the first run of CHS as well as experimental processing. Richman, as The Coretec Group’s domestic supply partner, will accelerate the domestic delivery times of CHS to customers and partners in the U.S.
“Richman’s expertise in custom synthesis from lab-scale to production is crucial to Coretec’s success. We additionally look forward to a collaborative relationship, working directly with their chemists and engineers on site as appropriate,” said Michelle Tokarz, vice president of partnerships and innovation at Coretec Group.
Christopher Kulp, chief commercial officer of RCI, added: “The Coretec Group’s engineered silicon technology is a game-changer for the energy, display, and printable electronics markets. We are proud to provide a domestic development and scale-up solution that meets the company’s rigorous technical demands.”
Founded in 1988, Lower Gwynedd, Penn.-based Richman Chemical offers process development, regulatory assistance, small-to-large-scale manufacturing, and project management. More at www.richmanchemical.com.
Coretec is developing a portfolio of engineered silicon to improve energy-focused verticals, including electric vehicle and consumer batteries, solid-state lighting (LEDs), and semiconductors, as well as 3D volumetric displays and printable electronics. Coretec serves the global technology markets in energy, electronics, semiconductor, solar, health, environment, and security. More at www.thecoretecgroup.com.